Eterna Therapeutics
ERNA
#10589
Rank
A$6.16 M
Marketcap
A$0.21
Share price
3.32%
Change (1 day)
-95.45%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): A-$111.33

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$106.42. In 2022 the company made an earnings per share (EPS) of A-$174.59 an increase over its 2021 EPS that were of A-$1,153.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$111.33
2022A-$174.59-84.86%
2021A-$1,153

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.86-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$2.57-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A-$2.80-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.18-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$1.72-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$0.72-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA